BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang HH, Portincasa P, Wang DQ. Update on the Molecular Mechanisms Underlying the Effect of Cholecystokinin and Cholecystokinin-1 Receptor on the Formation of Cholesterol Gallstones. Curr Med Chem 2019;26:3407-23. [PMID: 28625150 DOI: 10.2174/0929867324666170619104801] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Xin J, Qin M, Ye G, Gong H, Li M, Sui X, Liu B, Fu Q, He Z. Hydrophobic ion pairing-based self-emulsifying drug delivery systems: a new strategy for improving the therapeutic efficacy of water-soluble drugs. Expert Opin Drug Deliv 2023;20:1-11. [PMID: 36408589 DOI: 10.1080/17425247.2023.2150758] [Reference Citation Analysis]
2 Pavić T, Pelajić S, Blažević N, Kralj D, Milošević M, Mikolasevic I, Lerotic I, Hrabar D. Gut peptide changes in patients with obstructive jaundice undergoing biliary drainage: A prospective case control study. World J Clin Cases 2022; 10(17): 5551-5565 [DOI: 10.12998/wjcc.v10.i17.5551] [Reference Citation Analysis]
3 Sun H, Warren J, Yip J, Ji Y, Hao S, Han W, Ding Y. Factors Influencing Gallstone Formation: A Review of the Literature. Biomolecules 2022;12:550. [DOI: 10.3390/biom12040550] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 易 付. Research Progress on Mechanism, Prevention and Treatment of Gallstone Formation after Gastrectomy. ACM 2022;12:3214-3220. [DOI: 10.12677/acm.2022.124463] [Reference Citation Analysis]
5 Shateri K, Halimi shabestari F, Pashaei MR. Gallstone Frequency in Adults With Celiac Disease: Results of a Population-Based Celiac Disease Registry From West Azerbaijan, IRAN. Dis Diagn 2022;11:14-18. [DOI: 10.34172/ddj.2022.04] [Reference Citation Analysis]
6 Parra-Landazury NM, Cordova-Gallardo J, Méndez-Sánchez N. Obesity and Gallstones. Visc Med 2021;37:394-402. [PMID: 34722722 DOI: 10.1159/000515545] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Huang L, Ding C, Si X. Changes in the interstitial cells of Cajal in the gallbladder of guinea pigs fed a lithogenic diet. Exp Ther Med 2021;22:823. [PMID: 34131446 DOI: 10.3892/etm.2021.10255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Wang HH, Portincasa P, Liu M, Tso P, Wang DQ. An Update on the Lithogenic Mechanisms of Cholecystokinin a Receptor (CCKAR), an Important Gallstone Gene for Lith13. Genes (Basel) 2020;11:E1438. [PMID: 33260332 DOI: 10.3390/genes11121438] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Cortés VA, Barrera F, Nervi F. Pathophysiological connections between gallstone disease, insulin resistance, and obesity. Obes Rev 2020;21:e12983. [PMID: 31814283 DOI: 10.1111/obr.12983] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
10 Sensfuss U, Kruse T, Skyggebjerg RB, Uldam HK, Vestergaard B, Huus K, Vinther TN, Reinau ME, Schéele S, Clausen TR. Structure–Activity Relationships and Characterization of Highly Selective, Long-Acting, Peptide-Based Cholecystokinin 1 Receptor Agonists. J Med Chem 2019;62:1407-19. [DOI: 10.1021/acs.jmedchem.8b01558] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
11 Di Ciaula A, Portincasa P. Recent advances in understanding and managing cholesterol gallstones. F1000Res. 2018;7. [PMID: 30345010 DOI: 10.12688/f1000research.15505.1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]